Challenges in interpreting cytokine data in COVID-19 affect patient care and management
Author(s) -
Stephen Y. Wang,
Takehiro Takahashi,
Alexander B. Pine,
William Damsky,
Michael Simonov,
Yanhua Zhang,
Elizabeth Kieras,
Christina Price,
Brett King,
Mark D. Siegel,
Gary V. Désir,
Alfred Ian Lee,
Akiko Iwasaki,
Hyung J. Chun
Publication year - 2021
Publication title -
plos biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.127
H-Index - 271
eISSN - 1545-7885
pISSN - 1544-9173
DOI - 10.1371/journal.pbio.3001373
Subject(s) - covid-19 , biology , pandemic , cytokine , disease management , disease , coronavirus , limiting , data science , immunology , virology , medline , outbreak , infectious disease (medical specialty) , computer science , medicine , pathology , mechanical engineering , biochemistry , systematic review , engineering
Challenges in using cytokine data are limiting Coronavirus Disease 2019 (COVID-19) patient management and comparison among different disease contexts. We suggest mitigation strategies to improve the accuracy of cytokine data, as we learn from experience gained during the COVID-19 pandemic.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom